Darren S Cline
CIK 1633639 · Chief Commercial Officer · last filed 2026-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$442.5K
Companies
7
Total Filings
51
Lifetime Open-Market Net
-$5.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Director | 251,405 | $1.76 | $442.5K | $93.9K | 7 | 2026-03-25 |
| XENE | Chief Commercial Officer | — | $52.10 | — | $0 | 2 | 2026-01-09 |
| PLRX | Director | — | $1.13 | — | $0 | 4 | 2025-06-09 |
| IPI Legacy Liquidation Co (IMPL) Delisted | Director | — | $0.24 | — | $0 | 2 | 2023-06-20 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | U.S. Chief Commercial Officer | 5,556 | $218.96 | $1.22M | $0 | 5 | 2021-03-04 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Director | 0 | — | — | $0 | 3 | 2020-06-10 |
| Seagen Inc. (SGEN) Delisted | EVP, Commercial | 72,556 | $228.74 | $16.60M | -$5.46M | 27 | 2018-11-30 |
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-29 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +9,156 | $19.0K | EDGAR |
| 2019-06-28 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2019-05-30 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | +29,424 | $38 | EDGAR |
| 2018-11-30 | Seagen Inc. (SGEN) Delisted | Sell (S) | −7,000 | -$440.2K | EDGAR |
| 2018-11-21 | Seagen Inc. (SGEN) Delisted | Sell (S) | −4,167 | -$236.2K | EDGAR |
| 2018-09-04 | Seagen Inc. (SGEN) Delisted | Grant (A) | +18,644 | $0 | EDGAR |
| 2018-08-29 | Seagen Inc. (SGEN) Delisted | Sell (S) | −4,784 | -$355.1K | EDGAR |
| 2018-06-22 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +20,468 | $0 | EDGAR |
| 2018-06-14 | Seagen Inc. (SGEN) Delisted | Mixed | −1,968 | -$537.8K | EDGAR |
| 2018-05-11 | Seagen Inc. (SGEN) Delisted | Mixed | — | -$352.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.